The Vietnam clinical microbiology market was valued at USD 56.95 Million in 2025, driven by government initiatives promoting healthcare infrastructure and rapid diagnostic adoption across the region. The market is anticipated to grow at a CAGR of 5.50% during the forecast period of 2026-2035, with the values likely to reach USD 97.28 Million by 2035. Increasing infectious disease prevalence boosts demand for advanced microbiology diagnostics. The market benefits from expanding healthcare infrastructure and rising infectious disease awareness.
Base Year
Historical Period
Forecast Period
In 2023, tuberculosis cases in Vietnam rose by 2.2% from 2022, reflecting a growing disease burden. This increase drives demand for advanced clinical microbiology solutions, significantly fueling the market’s growth and innovation efforts.
In April 2025, DKSH co-hosted PacBio’s flagship PRISM genomics conference in Vietnam, enhancing local access to advanced sequencing technologies. Such collaboration is expected to accelerate innovation and drive growth in the Vietnam clinical microbiology market.
The market is growing rapidly due to rising infectious disease prevalence and increased healthcare investments. The expansion is further driven by major diagnostic companies, technology innovators, and growing government support, enhancing local testing capabilities.
Compound Annual Growth Rate
5.5%
Value in USD Million
2026-2035
*this image is indicative*
Clinical microbiology is a vital field of laboratory medicine that studies microorganisms such as bacteria, viruses, fungi, and parasites to diagnose infectious diseases. It aids in identifying pathogens, determining drug resistance, and supporting clinical decisions through accurate diagnostic techniques. The market is witnessing notable growth, driven by rising infectious disease prevalence, improved diagnostic infrastructure, and expanding government healthcare programs. Increasing adoption of molecular diagnostics and partnerships with international diagnostic firms further strengthen market development. The market is poised to grow at a CAGR of 5.50% during the forecast period of 2026–2035, reflecting its expanding role in Vietnam's evolving healthcare landscape.
Surging HIV Burden to Accelerate the Demand in Clinical Microbiology in Vietnam
The increasing prevalence of HIV infections is a significant driver for the growth of the market. According to Ngoan Tran Le et al., 2025, in 2023, the country recorded 6,100 new HIV infections and 4,100 AIDS-related deaths. High infection rates among key populations—12.5% in men, 9.1% in people who inject drugs (PWID), and 2.5% underscore the urgent need for advanced diagnostic tools. These epidemiological trends are expected to drive continuous investments and technological advancements, contributing to the expansion of Vietnam’s clinical microbiology sector.
Some of the notable trends in the market are increasing international collaborations and enhanced strategies to combat antimicrobial resistance.
Rising International Collaborations Propel Vietnam Clinical Microbiology Market Growth
The increasing emphasis on international collaborations is a key market trend, expected to accelerate the development and enhance the availability of advanced biomedical technologies. This approach facilitates technology transfer, research partnerships, and early access to innovative treatments such as mRNA-based vaccines. For example, in May 2025, Vietnam Vaccine Company (VNVC) partnered with the Russian Direct Investment Fund (RDIF) to jointly develop and produce next-generation vaccines and biological drugs. Such strategic alliances are expected to strengthen Vietnam’s capabilities in high-tech biomedical research and production, thereby driving significant market growth.
Emphasis on Mitigating Antimicrobial Resistance to Accelerate the Vietnam Clinical Microbiology Market Demand
The growing focus on antimicrobial resistance (AMR) mitigation is driving enhanced investments in clinical microbiology capabilities, including advanced diagnostics and surveillance systems. This trend reflects increasing government and healthcare sector commitments to control resistant infections and improve microbial monitoring. For example, in November 2024, Vietnam’s Ministry of Health launched a comprehensive AMR action plan emphasizing laboratory capacity building and nationwide surveillance. Such initiatives are poised to accelerate market growth by expanding demand for clinical microbiology solutions.
Respiratory Diseases to Lead the Market Segmentation By Application
Respiratory diseases are expected to dominate the market, primarily due to the high and rising prevalence of chronic respiratory conditions. As reported by Thuy Thanh Phan et al., 2025, chronic obstructive pulmonary disease (COPD) affects an estimated 7% to 10% of the Vietnamese population, highlighting the need for accurate and timely microbiological diagnostics. This growing burden is likely to accelerate the demand for respiratory disease testing. Other key applications include bloodstream infections, urinary tract infections, gastrointestinal diseases, sexually transmitted diseases, periodontal disease, and others, all projected to experience steady market growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Becton, Dickinson and Company (BD), headquartered in Franklin Lakes, New Jersey, is a leading global medical technology firm. BD plays a vital role in the clinical microbiology market by providing comprehensive specimen collection devices, culture media, and automation-ready plates that enhance pathogen detection and diagnostic accuracy. Their products support laboratories worldwide, including Vietnam, facilitating timely and reliable microbiological testing.
Established in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche Ltd. is a global leader in molecular diagnostics and clinical microbiology. The company develops innovative PCR-based tests for oncology, virology, and microbiology, widely used by hospitals and laboratories worldwide. Roche is advancing next-generation sequencing and automated sample preparation technologies, significantly enhancing diagnostic accuracy and efficiency in the clinical microbiology market.
Bio-Rad Laboratories, Inc. is a global leader in life sciences and clinical diagnostics. It was headquartered in Hercules, California, and was established in 1952. The company offers advanced products in microbiology testing, digital PCR, immunoassays, and infectious disease testing. Bio-Rad is actively involved in the clinical microbiology market, providing innovative solutions to enhance diagnostic accuracy and laboratory efficiency worldwide.
Headquartered in Marcy-l'Étoile, France, and established in 1963, bioMérieux SA is a global leader in in vitro diagnostics. The company offers advanced microbiology testing solutions, including culture, identification, and antibiotic susceptibility testing. bioMérieux is actively involved in the clinical microbiology market, providing innovative diagnostics to improve infectious disease detection and antimicrobial resistance monitoring worldwide.
Other key players in the market include Abbott, Thermo Fisher Scientific Inc., QIAGEN, Danaher Corporation, Agilent Technologies, Inc., and Shimadzu Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share